rs34162630

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001256789.3(CACNA1F):​c.1523G>A​(p.Arg508Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0233 in 1,188,489 control chromosomes in the GnomAD database, including 258 homozygotes. There are 9,016 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R508W) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.017 ( 28 hom., 576 hem., cov: 23)
Exomes 𝑓: 0.024 ( 230 hom. 8440 hem. )

Consequence

CACNA1F
NM_001256789.3 missense

Scores

3
8
4

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 7.83

Publications

15 publications found
Variant links:
Genes affected
CACNA1F (HGNC:1393): (calcium voltage-gated channel subunit alpha1 F) This gene encodes a multipass transmembrane protein that functions as an alpha-1 subunit of the voltage-dependent calcium channel, which mediates the influx of calcium ions into the cell. The encoded protein forms a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. Mutations in this gene can cause X-linked eye disorders, including congenital stationary night blindness type 2A, cone-rod dystropy, and Aland Island eye disease. Alternatively spliced transcript variants encoding multiple isoforms have been observed. [provided by RefSeq, Aug 2013]
CACNA1F Gene-Disease associations (from GenCC):
  • Aland island eye disease
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P
  • CACNA1F-related retinopathy
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • congenital stationary night blindness 2A
    Inheritance: XL Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • X-linked cone-rod dystrophy 3
    Inheritance: XL Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • cone-rod dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • congenital stationary night blindness
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.02172777).
BP6
Variant X-49226037-C-T is Benign according to our data. Variant chrX-49226037-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 402468.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0174 (1935/110942) while in subpopulation NFE AF = 0.0262 (1385/52829). AF 95% confidence interval is 0.0251. There are 28 homozygotes in GnomAd4. There are 576 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check.
BS2
High AC in GnomAd4 at 1935 XL,AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001256789.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1F
NM_001256789.3
MANE Select
c.1523G>Ap.Arg508Gln
missense
Exon 13 of 48NP_001243718.1O60840-2
CACNA1F
NM_005183.4
c.1556G>Ap.Arg519Gln
missense
Exon 13 of 48NP_005174.2O60840-1
CACNA1F
NM_001256790.3
c.1361G>Ap.Arg454Gln
missense
Exon 13 of 48NP_001243719.1O60840-4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1F
ENST00000323022.10
TSL:1 MANE Select
c.1523G>Ap.Arg508Gln
missense
Exon 13 of 48ENSP00000321618.6O60840-2
CACNA1F
ENST00000376265.2
TSL:1
c.1556G>Ap.Arg519Gln
missense
Exon 13 of 48ENSP00000365441.2O60840-1
CACNA1F
ENST00000376251.5
TSL:1
c.1361G>Ap.Arg454Gln
missense
Exon 13 of 48ENSP00000365427.1O60840-4

Frequencies

GnomAD3 genomes
AF:
0.0175
AC:
1939
AN:
110895
Hom.:
28
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00263
Gnomad AMI
AF:
0.187
Gnomad AMR
AF:
0.00714
Gnomad ASJ
AF:
0.00152
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0224
Gnomad FIN
AF:
0.0321
Gnomad MID
AF:
0.0212
Gnomad NFE
AF:
0.0262
Gnomad OTH
AF:
0.0108
GnomAD2 exomes
AF:
0.0174
AC:
2498
AN:
143850
AF XY:
0.0183
show subpopulations
Gnomad AFR exome
AF:
0.00354
Gnomad AMR exome
AF:
0.00421
Gnomad ASJ exome
AF:
0.00323
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0342
Gnomad NFE exome
AF:
0.0250
Gnomad OTH exome
AF:
0.0231
GnomAD4 exome
AF:
0.0239
AC:
25796
AN:
1077547
Hom.:
230
Cov.:
32
AF XY:
0.0240
AC XY:
8440
AN XY:
351193
show subpopulations
African (AFR)
AF:
0.00286
AC:
74
AN:
25886
American (AMR)
AF:
0.00399
AC:
128
AN:
32117
Ashkenazi Jewish (ASJ)
AF:
0.00242
AC:
46
AN:
19020
East Asian (EAS)
AF:
0.0000689
AC:
2
AN:
29016
South Asian (SAS)
AF:
0.0211
AC:
1087
AN:
51615
European-Finnish (FIN)
AF:
0.0362
AC:
1416
AN:
39115
Middle Eastern (MID)
AF:
0.0177
AC:
73
AN:
4115
European-Non Finnish (NFE)
AF:
0.0266
AC:
22092
AN:
831342
Other (OTH)
AF:
0.0194
AC:
878
AN:
45321
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
1009
2017
3026
4034
5043
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
842
1684
2526
3368
4210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0174
AC:
1935
AN:
110942
Hom.:
28
Cov.:
23
AF XY:
0.0173
AC XY:
576
AN XY:
33266
show subpopulations
African (AFR)
AF:
0.00262
AC:
80
AN:
30525
American (AMR)
AF:
0.00713
AC:
75
AN:
10523
Ashkenazi Jewish (ASJ)
AF:
0.00152
AC:
4
AN:
2636
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3498
South Asian (SAS)
AF:
0.0221
AC:
58
AN:
2626
European-Finnish (FIN)
AF:
0.0321
AC:
190
AN:
5927
Middle Eastern (MID)
AF:
0.0140
AC:
3
AN:
215
European-Non Finnish (NFE)
AF:
0.0262
AC:
1385
AN:
52829
Other (OTH)
AF:
0.0100
AC:
15
AN:
1494
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
66
132
198
264
330
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0216
Hom.:
1398
Bravo
AF:
0.0158
TwinsUK
AF:
0.0272
AC:
101
ALSPAC
AF:
0.0267
AC:
77
ESP6500AA
AF:
0.00314
AC:
12
ESP6500EA
AF:
0.0250
AC:
168
ExAC
AF:
0.0158
AC:
1884

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not provided (3)
-
-
2
not specified (2)
-
-
1
Congenital stationary night blindness 2A (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.27
BayesDel_addAF
Benign
-0.14
T
BayesDel_noAF
Uncertain
0.050
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.69
D
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.91
D
MetaRNN
Benign
0.022
T
MetaSVM
Uncertain
0.59
D
MutationAssessor
Pathogenic
3.1
M
PhyloP100
7.8
PrimateAI
Uncertain
0.63
T
PROVEAN
Uncertain
-3.7
D
REVEL
Pathogenic
0.71
Sift
Benign
0.048
D
Sift4G
Uncertain
0.011
D
Polyphen
1.0
D
Vest4
0.69
MPC
0.91
ClinPred
0.029
T
GERP RS
3.6
Varity_R
0.50
gMVP
0.81
Mutation Taster
=93/7
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34162630; hg19: chrX-49082499; API